Sort
85,873 grants matching “alzheimers”
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2024 · AG
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · AG
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
$929,705Jerold Chun · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
La Jolla Interdisciplinary Neuroscience Center Cores
$929,553Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2011 · NS
Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia
$929,442Michael Paasche-Orlow · Boston Medical Center · R01 · FY2022 · AG
Engagement in Longevity and Medicine (ELM)
$929,347Joshua Chodosh · New York University School Of Medicine · R24 · FY2021 · AG
High-Throughput Technology for Global Protein and Metabolite Analysis
$929,087Joshua J Coon · University Of Wisconsin-Madison · R35 · FY2016 · GM
Neuroimaging Core
$929,085Peter Thornton Fox · University Of Texas Hlth Science Center · U19 · FY2024 · AG
Longitudinal Investigation of Cardiorespiratory Fitness and AD Biomarkers in an At-Risk Cohort
$928,957Ozioma C Okonkwo · University Of Wisconsin-Madison · R01 · FY2023 · AG
Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics
$928,904Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2025 · AG
Microbial Impact on NeuroDegeneration in Alzheimer's Dementia: MIND-AD
$928,646Adam Peter Spira · Johns Hopkins University · R01 · FY2024 · AG
Stability and Robustness of Hippocampal Representations of Space
$928,475Athanassios Siapas · California Institute Of Technology · R01 · FY2024 · NS
Cerebral hemodynamic impairment in symptomatic and asymptomatic Alzheimer's Disease
$927,952Deqiang Qiu · Emory University · R01 · FY2024 · AG
UAMS Alzheimer's Disease Core Center
$927,850University Of Arkansas Med Scis Ltl Rock · P30 · FY2001 · AG
PET, APOE &The Preclinical Course of Alzheimer Disease
$927,698Banner Good Samaritan Medical Center · R01 · FY2003 · MH
Pre-clinical study to fulfill FDA requirements for the completion of AV-1959 IND
$927,669Michael G Agadjanyan · Institute For Molecular Medicine · U01 · FY2018 · AG
National Cell Respository for Alzheimer's Disease (NCRAD) (U24)
$927,002Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2014 · AG
Impact of ovarian hormone suppression on regional and global brain architecture and cognition
$926,907Matthew S Panizzon · University Of California, San Diego · R01 · FY2024 · AG
Clinical Core
$926,874Douglas R Galasko · University Of California, San Diego · P50 · FY2016 · AG
Clinical Core
$926,874Douglas R Galasko · University Of California, San Diego · P50 · FY2014 · AG
Neuroimaging Core
$926,769Kejal Kantarci · Mayo Clinic Rochester · U19 · FY2025 · AG
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study
$926,706Joe Verghese · Albert Einstein College Of Medicine, Inc · R56 · FY2017 · AG
Building a two-way communication system: Bio-orthogonal superhydrophobic nanoparticles for controlled stimulation and real-time sensing of neurotransmitters
$926,703Maral Mousavi · University Of Southern California · DP2 · FY2025 · GM
Anti-Aging Mitochondrial Protein Therapy for Alzheimer?s Disease and Sarcopenia
$926,657James Pepper Bennett · Gencia Corporation · R42 · FY2009 · AG
Early detection and monitoring of Alzheimers Disease and Related Dementias using non-semantic linguistic and acoustic features of speech derived from hearing aids
$926,545Brian John Bischoff · Headwaters Innovation, Inc. · R44 · FY2025 · AG